Healthcare Sector - Statistics

Description	Market Cap.	P/E	ROE %	Div. Yield %	Long-Term Debt to Equity	Price to BV	NP Margin  %
Sector: Healthcare	51058.4B	20.26	16	3.74	69.99	17.99	16
Industries
Biotechnology	2509.2B	57.8	8.7	2.07	38.21	7.38	11.9
Diagnostic Substances	12.0B	179.6	2.5	3.54	36.57	4.99	2.7
Drug Delivery	69.4B	0	0	0.36	86.31	-9.05	-1.2
Drug Manufacturers - Major	45511.9B	17.2	15.8	4.02	72.17	19.89	16.7
Drug Manufacturers - Other	191.8B	28.9	13.4	1	253.56	17.85	14.1
Drug Related Products	22.2B	36.5	14.9	0.77	58	13.95	9.5
Drugs - Generic	853.3B	50.1	7.6	0.13	50.97	-22	6
Health Care Plans	180.1B	11.8	17.2	1.22	61.83	10.08	4.5
Home Health Care	4.9B	24.1	12	2.22	71.65	-11.1	5.7
Hospitals	318.7B	10	144	0.24	75.2	-2.49	4.3
Long-Term Care Facilities	9.3B	63.7	2.4	0.88	206.77	4.05	0.9
Medical Appliances & Equipment	898.4B	16.3	14.1	1.61	32.45	6.06	13.7
Medical Instruments & Supplies	322.2B	24.1	13.5	1.63	42.34	16.88	13.6
Medical Laboratories & Research	131.9B	202.8	1.5	0.81	78.05	-9.45	0.8
Medical Practitioners	3.3B	7.6	12.7	6.04	45.08	5.59	4.3
Specialized Health Services	19.8B	17.3	17.6	1.94	121.04	-10	9.4

The data is a 2 days older but the proportion of Biotechnology Industry in the Healthcare sector in US is 2nd after Major drug manufacturers. P/E of Medical Laboratories & Research is ten times more than the sector but the net profit margin is only 0.8%. Apparently the reasons are not coming into my mind but I have found the statistics interesting especially when looked together.